Part of funding portal member: truCrowd, Inc.
Mobile Menu

Greenzone Pharms LLC

First CBD Hemp Processor in Illinois
INVEST

20dd08hh

Time left to invest

58% funded (of minimum target)

min$10k

max$1070k

funding goal 

$10k - $1070k

funding goal 

Regulation CF

exemption used 

Regulation CF

exemption used 

$5,000,000

pre money valuation 

$200.00

min investment 

$5,760

amount committed 

23

investors 


Security Type
Units of Revenue Participation
Revenue Participation: 10%
Potential Return: 3X (3 times)
Early Buyback Potential Return: 5X

Pitch

Who are we

Greenzone is a licensed grower of hemp in the state of Wisconsin and a CBD extractor and processor in the State of Illinois. From cloning and genetics to Co2 Supercritical oil extraction to brand development of tinctures (drops), gummies, lotions, and other CBD infused products, Greenzone is truly a verticle soil-to-shelf company.

 

Money had this to say in its October 3, 2019 Article online (money.com):

 

"CBD is in the middle of a business boom. Sometimes known as “the other weed,” cannabis-derived cannabidiol is quickly catching on in products marketed and sold throughout the United States, ranging from infused tinctures and oils to premium chocolate bars and even a $50 jar of “rejuvenating” clay mask ... that utilize the anti-inflammatory properties of the cannabinoid to reduce redness and breakouts.

The CBD industry is already worth $1 billion, and Wall Street experts think it could reach 16billion by 2025. Meanwhile, celebrities are quickly flocking to this alternative-pot market,"

 

Think of CBD as the Medical "PART" of Medical Marijuana.

 

Problem

CBD is truely an amazing molecule, and millions of people are learning about it every day. There is a lack of education and properly formulated quality products on the market. The FDA recently tested 23 brands and only 3 provided what the packaging claimed.  Greenzone is here to change that, we will educate the consumer and also provide a truly high-quality 3rd party Lab tested CBD product to the customer through retail and online sales.

 

More and more Americans are turning to CBD to address their medical problems naturally. Below you can see who is using CBD and for what purposes.

 

Solution

We proudly call our CBD oil the Gold Standard oil. With third party testing, 110% formulation procedures as well as beautifully designed packaging, Greenzone has a significant advantage in this aggressively growing industry. 

 

Achievement & Traction

Greenzone has been invited to speak about CBD in front of the Chicago Fraternal Order of Police, as well as at the Illinois Rural Development Expo, we even developed a product called First Responder, for Police, Firefighters, and Paramedics to ensure Zero THC CBD oil can be used safely without any career drug test failures.

 Also, Greenzone has developed huge audience of Hemp Industry peers by founding the Wisconsin Hemp Cooperative and the Illinois Hemp Cooperative facebook pages giving us direct access to over 1000 Hemp Growers, Processors and CBD Product companies.

 

Growing our distribution network is a key goal we intend to expand. We currently are in a handful of 7/11 stores and vape stores. We intend to expand that network to over 1000 retail locations.

 

 

Market

The CBD Hemp Oil market is one of the fastest-growing industries in the United States and across the Globe. Due to the benefits of CBD, it has been called Nature's Miracle and for good reason, it really works. We are proud of our products great effects and the lives it has changed.

 

According to Brightfield Group, sales of hemp-derived CBD products almost doubled to $170 million in 2016. Experts have already suggested that it will become a billion-dollar industry by 2020 or 2021.

 

The Hemp Industries Association (HIA) reported total U.S. retail sales of hemp products of nearly $700 million in 2016. HIA claims that U.S. hemp retail sales have increased by about 10% to more than 20% annually since 2011. Much of this growth is attributable to sales of hemp-based body products, supplements, and foods. Combined, these categories accounted for more than two-thirds of the value of U.S. retail CBD sales in 2016.

 

According to a new report “Global State Of Hemp: 2019 Industry Outlook” from New Frontier Data, U.S. sales of hemp products estimated at about $1 billion in 2018, are projected to grow 27% annually to reach $22 billion by 2022.

 

Hemp imports to the United States – consisting of hemp seeds and fibers often used as inputs for use in further manufacturing – totaled $67.3 million in 2017, 57% decrease in seed imports from the previous year, and the first half of 2018 puts the import market on pace for a 20% decrease. This downward trend is expected to continue as the U.S. hemp market continues to mature and expand.

 

 

Competition

There are many CBD companies but most are marketing companies with lower than promised CBD levels. Greenzone plans to educate the consumer and provide the Gold Standard in CBD products.

 

We intend to take advantage of the new interest in Big Box Stores by actively marketing to stores such as Walmart, CVS, and Walgreens.

 

Business Model

Our revenue streams include: 

  • Farm ready Hemp Clones
  • Farm Co2 Supercritical Extraction
  • Toll processing of distillate, Isolate and T-Free Distillate
  • Private label and White label Manufacturing for other CBD companies
  • Brand Development and Formulations
  • Powder Designer CBD encapsulation using our 1200 capsule per min. encapsulation machine
  • Hemp Industry Consulting and CBD Product Development services

 

 

Team

With over 25 years as an entrepreneur, our CEO Dan Marlow has brought many companies to market in the High Tech Sector. Including, Internet, Bitcoin, and Voice Over IP. Our Facilities foreman Mike Gawinski has 20 years of mechanical experience and our VP of Operations Theresa Marlow has a background in Medical Management as well as Hospitality operations.

 

Use of Funds

Updates

Dan Marlow
Dan Marlow2 months ago

"Separately, researchers at Tel Aviv University have begun developing a CBD-based drug that has been shown to be effective against inflammation for coronavirus-infected lung cells."
https://www.breitbart.com/middle-east/2020/04/25/israeli-hospital-to-begin-treating-virus-patients-with-cannabis/

 

 

Load More
1

Q&A


You must be logged in to be able to post a question.

Abdur-Raheim Braddox
Abdur-Raheim Braddox - Investor5 days ago
As a future investor, will my profits be automatically transferred to my account within the projected months that you stated in your comments.
Derwin Wallace
Derwin Wallace - Investor2 months ago
Cannabis Investor Magazine has emailed you at gz@ync.net
Jessica Smith
Jessica Smith - Investor2 months ago
Greetings how long does it take to become a secure holder?
Dan Marlow
Dan Marlow - Issuer    
Only about 15 min follow the instructions on this portal or reach out gz@ync.net

2 months ago
Derwin Wallace
Derwin Wallace - Investor2 months ago
Have you looked at increasing awareness and exposure for your capital raise via Cannabis Investor Magazine and HempCBD Investor Magazine?
Dan Marlow
Dan Marlow - Issuer    
No I haven’t please reach out gz@ync.net

2 months ago
Morgan Carroll
Morgan Carroll - Issuer 5 months ago
How long will it take to see investment income
Dan Marlow
Dan Marlow - Issuer    
Hello! All depends on how fast we fund the campaign! We would like to see this happen in 4-5 months then with expanding distribution I would estimate very soon a matter of 3-4 more months! We will distribute revenue sharing ongoing so you do not need wait till then end of the expansion by any means. So in total a conservative estimate is under 9 months or maybe even less! After that Revenue sharing checks will be going out.
Let us know if you have any other great questions!

5 months ago

Documents

Start-up Valuation View Download
Offering Statement View Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Use of Proceeds
The allocation of the use of proceeds among the categories of anticipated expenditures represents management’s best estimates based on the current status of the Company’s proposed operations, plans, investment objectives, capital requirements, and financial conditions. Future events, including changes in economic or competitive conditions of our business plan or the completion of less than the total Offering, may cause the Company to modify the above-described allocation of proceeds. The Company’s use of proceeds may vary significantly in the event any of the Company’s assumptions prove inaccurate. We will retain broad discretion in the allocation of the net proceeds from this Offering, reserve the right to change the allocation of net proceeds from the Offering as unanticipated events or opportunities arise and could utilize the proceeds in ways that do not necessarily improve our results of operations or enhance the value of our Common Stock. Additionally, the Company may from time to time need to raise more capital to address future needs that we may not have anticipated as of the date of this Offering Circular.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.
up

Back to top